# Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall

> **NCT00864032** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 8 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00864032
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864032, "Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00864032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*